These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37439454)

  • 1. Diabetic retinopathy and its relation to serum brain-derived neurotrophic factor level.
    Abd El-Hamid SM; Farrag EA; Gamal El-Deen AM
    Egypt J Immunol; 2023 Jul; 30(3):23-31. PubMed ID: 37439454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RELATIONSHIP BETWEEN STAGES OF DIABETIC RETINOPATHY AND LEVELS OF BRAIN-DERIVED NEUROTROPHIC FACTOR IN AQUEOUS HUMOR AND SERUM.
    Taşlipinar Uzel AG; UĞurlu N; Toklu Y; Çİçek M; Boral B; Şener B; ÇaĞil N
    Retina; 2020 Jan; 40(1):121-125. PubMed ID: 30300266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Serum Brain-Derived Neurotrophic Factor Levels in Diabetic Patients With and Without Retinopathy.
    Rashid RR; Fazal A; Khan QU; Ul Qamar M; Ahmed F; Laique T
    Cureus; 2020 Dec; 12(12):e12028. PubMed ID: 33457130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOW SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR BUT NOT BRAIN-DERIVED NEUROTROPHIC FACTOR GENE VAL66MET POLYMORPHISM IS ASSOCIATED WITH DIABETIC RETINOPATHY IN CHINESE TYPE 2 DIABETIC PATIENTS.
    Guo M; Liu H; Li SS; Jiang FL; Xu JM; Tang YY
    Retina; 2017 Feb; 37(2):350-358. PubMed ID: 27355244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy.
    Kaviarasan K; Jithu M; Arif Mulla M; Sharma T; Sivasankar S; Das UN; Angayarkanni N
    Metabolism; 2015 Sep; 64(9):958-66. PubMed ID: 26004392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor in non-proliferative diabetic retinopathy with diabetic macular edema.
    Jun YH; Kim ST
    Eur J Ophthalmol; 2021 Jul; 31(4):1915-1919. PubMed ID: 32686489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats.
    Ola MS; Nawaz MI; El-Asrar AA; Abouammoh M; Alhomida AS
    Cell Mol Neurobiol; 2013 Apr; 33(3):359-67. PubMed ID: 23271640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma levels of brain derived neurotrophic factor are potential risk factors for diabetic retinopathy in Chinese type 2 diabetic patients.
    Liu SY; Du XF; Ma X; Guo JL; Lu JM; Ma LS
    Mol Cell Endocrinol; 2016 Jan; 420():152-8. PubMed ID: 26493466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis.
    Moosaie F; Mohammadi S; Saghazadeh A; Dehghani Firouzabadi F; Rezaei N
    PLoS One; 2023; 18(2):e0268816. PubMed ID: 36787304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy.
    Gholamhossein Y; Behrouz H; Asghar Z
    Korean J Ophthalmol; 2014 Oct; 28(5):373-8. PubMed ID: 25276078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Pentraxin 3 level as a recent biomarker of diabetic retinopathy in Egyptian patients with diabetes.
    Elbana KA; Salem HM; Abdel Fattah NR; Etman E
    Diabetes Metab Syndr; 2019; 13(4):2361-2364. PubMed ID: 31405644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor levels and sleep disorders in Chinese healthy and newly diagnosed type 2 diabetic subjects.
    Wei H; Qu H; Wang H; Ji B; Deng H
    J Diabetes; 2017 Feb; 9(2):180-189. PubMed ID: 27038292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility group box-1 induces decreased brain-derived neurotrophic factor-mediated neuroprotection in the diabetic retina.
    Abu El-Asrar AM; Nawaz MI; Siddiquei MM; Al-Kharashi AS; Kangave D; Mohammad G
    Mediators Inflamm; 2013; 2013():863036. PubMed ID: 23766563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum insulin-like growth factor-I in diabetic retinopathy.
    Payne JF; Tangpricha V; Cleveland J; Lynn MJ; Ray R; Srivastava SK
    Mol Vis; 2011; 17():2318-24. PubMed ID: 21921983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.
    Koleva-Georgieva DN; Sivkova NP; Terzieva D
    Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into Diabetic and Vision-Threatening Retinopathy: Importance of Plasma Long Pentraxine 3 and Taurine Levels.
    Güngel H; Erdenen F; Pasaoglu I; Sak D; Ogreden T; Kilic Muftuoglu I
    Curr Eye Res; 2021 Jun; 46(6):818-823. PubMed ID: 33044093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile.
    Davarpanah M; Shokri-Mashhadi N; Ziaei R; Saneei P
    Sci Rep; 2021 Jul; 11(1):13773. PubMed ID: 34215825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimyeloperoxidase antibody is a biomarker for progression of diabetic retinopathy.
    Sinha S; Saxena S; Das S; Prasad S; Bhasker SK; Mahdi AA; Kruzliak P
    J Diabetes Complications; 2016; 30(4):700-4. PubMed ID: 26948921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.